Atrial fibrillation and thromboembolic stroke

W S Aronow1

  • 1Hebrew Hospital Home, Bronx, NY 10475.

Comprehensive Therapy
|January 1, 1994
PubMed

Insights

Long-term oral warfarin is recommended for atrial fibrillation patients with a history of embolism or valve disease to prevent stroke. Aspirin is an alternative for some patients, while younger lone atrial fibrillation patients may not need anticoagulation.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia associated with a high risk of thromboembolic stroke.
  • Effective anticoagulation strategies are crucial for stroke prevention in AF patients.
  • Current guidelines recommend tailored approaches based on patient risk factors and comorbidities.

Purpose of the Study:

  • To outline evidence-based recommendations for anticoagulation and rate control in patients with atrial fibrillation.
  • To differentiate treatment strategies based on AF type, patient age, and specific risk factors.
  • To provide guidance on the use of warfarin, aspirin, and rate-controlling medications.

Main Methods:

  • Review of existing clinical guidelines and landmark studies on anticoagulation in atrial fibrillation.
  • Analysis of patient subgroups including those with valvular heart disease, nonvalvular AF, and lone AF.
  • Evaluation of pharmacological agents for rate control and rhythm management.

Main Results:

  • Long-term oral warfarin is indicated for AF patients with a history of systemic embolism, mitral valve disease, nonvalvular AF, or mitral annular calcium to reduce thromboembolic stroke.
  • Aspirin (325 mg/d) is an alternative for nonvalvular AF patients with warfarin contraindications or low thromboembolic risk if younger than 75.
  • Elderly patients with lone AF should receive low-dose warfarin; younger lone AF patients (<60 years) should not receive anticoagulants.
  • Rate control can be achieved with digoxin, verapamil, diltiazem, and propranolol.
  • Antiarrhythmic drugs are not routinely recommended, but propranolol may be used for ventricular arrhythmias or post-conversion.

Conclusions:

  • Anticoagulation choice in atrial fibrillation requires careful consideration of individual patient risk factors and contraindications.
  • Warfarin remains a primary agent for stroke prevention in high-risk AF populations.
  • Rate control agents are effective for managing ventricular response in AF, with specific indications for propranolol.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...